- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
Vivanza Biosciences Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln
- Indian Private
- BSE Code : 4834.0
- ISIN : INE984E01035
-
Today’s Low
2.04 -
Today’s High
2.13

-
Open
2.04 -
Perv Close
2.07 -
52W Low
1.90 -
52W High
4.90
Key Indicators
-
P/E(TTM)
0.00
-
Mar.Cap (₹Cr.)
8.40
-
Div & Yield %
0.00
-
Book Value(₹)
1.01
-
Debt-Equity Ratio
1.45
-
AGM Date
22-Aug-2025
-
EPS
0.00
-
P/E Ratio
0.00
Financials Ratios
-
Debt-Equity Ratio
1.51
-
Mar.Cap (₹Cr.)
8.40
-
RONW (%)
12.60
-
ROCE (%)
10.23
Score Board
-
Equity (₹ in Cr.)
4.00
-
BV (₹)
1.00
-
Sales( ₹ in Cr.)
2.94
-
NP (in Cr.)
-0.70
-
NP Var(%)
-319.0
-
Div%
0.0
-
CPS (₹)
-0.20
-
EPS (₹)
-0.20
-
Traded Value (₹ in Lakhs)
8.40
-
52 Week High
4.90
-
52 Week Low
1.90
-
Price BSE
2.0
-
Price NSE
0.00
-
Market Capital( in Cr.)
8.40
-
P/C Ratio
-11.70
-
P/E Ratio
-11.50
-
Price Vs.BV
-0.20
-
13-Aug-2025( 05:55)
Results - Announcements - Vivan... - Net profit of Vivanza Bioscien...
-
09-Aug-2025( 04:27)
Corporate News - Vivan... - Vivanza Biosciences will hold...
-
13-May-2025( 07:37)
Results - Announcements - Vivan... - Net Loss of Vivanza Bioscience...
-
08-May-2025( 11:19)
Corporate News - Vivan... - Vivanza Biosciences will hold...
Navigate The Market With Confidence
Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions
Financials
All Values are in (₹Cr)Particulars(INCOME) | 2024 Mar | 2023 Mar | 2022 Mar | 2021 Mar | 2020 Mar | 2019 Mar |
---|---|---|---|---|---|---|
INCOME : | ||||||
Sales Turnover | 14.41 | 14.21 | 9.15 | 9.22 | 9.43 | 2.22 |
Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Sales | 14.41 | 14.21 | 9.15 | 9.22 | 9.43 | 2.22 |
Other Income | 0.05 | 0.39 | 0.83 | 0.50 | 0.53 | 0.00 |
Stock Adjustments | 0.19 | -0.62 | 1.83 | -0.46 | -1.06 | -0.37 |
Total Income | 14.65 | 13.98 | 11.81 | 9.26 | 8.90 | 1.85 |
EXPENDITURE : | ||||||
Raw Materials | 13.17 | 12.34 | 10.31 | 8.11 | 8.08 | 1.61 |
Power and Fuel Cost | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Employee Cost | 0.31 | 0.22 | 0.08 | 0.11 | 0.10 | 0.02 |
Other Manufacturing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 | 0.00 |
Selling and Administration Expenses | 0.26 | 0.21 | 0.34 | 0.35 | 0.42 | 0.24 |
Miscellaneous Expenses | 0.06 | 0.09 | 0.17 | 0.07 | 0.06 | 0.01 |
Employee Benefit Expenses | 0.31 | 0.22 | 0.08 | 0.11 | 0.10 | 0.02 |
Less: Preoperative Expenditure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Expenses | 13.79 | 12.86 | 10.90 | 8.64 | 8.67 | 1.88 |
Operating Profit | 0.86 | 1.12 | 0.90 | 0.63 | 0.24 | -0.03 |
Interest | 0.42 | 0.43 | 0.43 | 0.47 | 0.44 | 0.42 |
Gross Profit | 0.44 | 0.69 | 0.47 | 0.16 | -0.20 | -0.45 |
Depreciation | 0.01 | 0.00 | 0.01 | 0.01 | 0.00 | 0.00 |
Profit Before Tax | 0.43 | 0.69 | 0.46 | 0.15 | -0.20 | -0.45 |
Current Tax | 0.11 | 0.12 | 0.00 | 0.05 | 0.00 | 0.00 |
Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Deferred Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Reported Net Profit | 0.32 | 0.57 | 0.46 | 0.10 | -0.20 | -0.45 |
Extraordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Adjusted Net Profit | 0.32 | 0.57 | 0.46 | 0.10 | -0.20 | -0.45 |
Adjustment below Net Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P & L Balance brought forward | 0.40 | -0.17 | -0.63 | -0.73 | -0.53 | -0.08 |
Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P & L Balance carried down | 0.72 | 0.40 | -0.17 | -0.63 | -0.73 | -0.53 |
Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Equity Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Dividend Per Share(Rs) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Per Share-Unit Curr | 0.08 | 0.14 | 1.16 | 0.25 | -0.51 | 0.00 |
Earnings Per Share(Adj)-Unit Curr | 0.08 | 0.14 | 0.12 | 0.03 | - | - |
Book Value | 1.18 | 1.10 | 9.57 | 8.41 | 8.16 | 8.67 |
Book Value(Adj)-Unit Curr | 1.18 | 1.10 | 0.96 | 0.84 | - | - |
Company Background
Vivanza Biosciences LtdPharmaceuticals - Indian - Bulk Drugs & Formln
- Vivanza Biosciences Ltd
- BSE Code : 4834.0
- ISIN : INE984E01035
-
Incorporation Year
1982
-
Registered Office
403 Sarthik 2 Opp Rajpath Club
S G Highway, Ahmedabad,
Gujarat-380054 -
Telephone
91-07405699869
-
FAX
-
Chairman
-
Managing Director
Jayendra Mehta
-
Company Secretary
-
Auditor
Shivam Soni & Co
-
Face Value
1
-
Listing
BSE
-
Registrar
Purva Sharegistry (I) Pvt Ltd
9 ShivShakti Indl Es,
J R Boricha Marg,Lower Parel
Mumbai - Mumbai - 400 011
Vivanza Biosciences Ltd Peer Comparison
Select | Company Name | LTP (₹) | Revenue | Sales | P/E Ratio | ROCE % |
---|---|---|---|---|---|---|
Vivanza Biosci. | 2.10 | 14.47 | 14.41 | -9.13 | 8.98 | |
Abbott India | 31,909.75 | 6,684.73 | 6,409.15 | 46.69 | 44.95 | |
Astrazeneca Phar | 8,431.65 | 1,756.92 | 1,716.29 | 114.97 | 32.94 | |
P & G Health Ltd | 6,573.80 | 944.52 | 934.17 | 36.30 | 40.23 | |
Glaxosmi. Pharma | 2,799.50 | 3,866.05 | 3,723.49 | 50.34 | 58.72 | |
Cipla | 1,592.30 | 20,029.57 | 19,044.85 | 23.80 | 21.40 | |
Amrutanjan Healt | 701.35 | 437.58 | 421.23 | 37.19 | 20.84 | |
Guj. Themis Bio. | 399.70 | 152.47 | 150.80 | 97.73 | 27.21 | |
Fermenta Biotec. | 336.10 | 442.21 | 430.53 | 11.15 | 17.61 | |
Bliss GVS Pharma | 161.45 | 703.42 | 667.20 | 24.13 | 9.16 | |
Ambalal Sarabhai | 34.33 | 19.33 | 4.04 | 17.97 | 2.10 |